Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Päivi Junni"'
Autor:
Reijo Laaksonen, Mikko Katajamaa, Hannu Päivä, Marko Sysi-Aho, Lilli Saarinen, Päivi Junni, Dieter Lütjohann, Joél Smet, Rudy Van Coster, Tuulikki Seppänen-Laakso, Terho Lehtimäki, Juhani Soini, Matej Oresic
Publikováno v:
PLoS ONE, Vol 1, p e97 (2006)
BACKGROUND: Aggressive lipid lowering with high doses of statins increases the risk of statin-induced myopathy. However, the cellular mechanisms leading to muscle damage are not known and sensitive biomarkers are needed to identify patients at risk o
Externí odkaz:
https://doaj.org/article/73089aa923d2441d8757dd8ed15e155e
Autor:
Riitta Lahesmaa, Chetan Gadgil, Hemanta Kumar Kar, Vinaya Vijayan, Avinash Kumar, Tanveer Fatima, Manisha Tiwari, Pankaj Sharma, Parul Ganju, Lipi Thukral, Sangeeta Khanna, Päivi Junni, Archana Singh, Krishnamurthy Natarajan, Vishvabandhu Gotherwal, Rajesh S. Gokhale, Garima Malik, Rajni Rani, Vivek T. Natarajan, Ananthaprasad Holla, Aayush Gupta
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
In vitiligo, chronic loss of melanocytes and consequent absence of melanin from the epidermis presents a challenge for long-term tissue maintenance. The stable vitiligo patches are known to attain an irreversible depigmented state. However, the molec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deb7b75d82b2c3a0361e391670e4aa04
http://europepmc.org/articles/PMC5575244
http://europepmc.org/articles/PMC5575244
Autor:
Mikko Katajamaa, Matej Orešič, Tuulikki Seppänen-Laakso, Terho Lehtimäki, Juhani T. Soini, Lilli Saarinen, Joél Smet, Hannu Päivä, Päivi Junni, Reijo Laaksonen, Dieter Lütjohann, Marko Sysi-Aho, Rudy Van Coster
Publikováno v:
Laaksonen, R, Katajamaa, M, Päivä, H, Sysi-Aho, M, Saarinen, L, Junni, P, Lütjohann, D, Smet, J, Van Coster, R, Seppänen-Laakso, T, Lehtimäki, T, Soini, J & Oresic, M 2006, ' A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle ', PLoS ONE, vol. 1, no. 1 . https://doi.org/10.1371/journal.pone.0000097
PLoS ONE
PLoS ONE, Vol 1, p e97 (2006)
PLoS ONE
PLoS ONE, Vol 1, p e97 (2006)
Background: Aggressive lipid lowering with high doses of statins increases the risk of statin-induced myopathy. However, the cellular mechanisms leading to muscle damage are not known and sensitive biomarkers are needed to identify patients at risk o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a07e607ea9fb9b0a3f0908bacf86ce
https://cris.vtt.fi/en/publications/0e1cfd5f-3e9c-4f27-bff4-8e36886e612c
https://cris.vtt.fi/en/publications/0e1cfd5f-3e9c-4f27-bff4-8e36886e612c
